Vice President of Business Development shares insight on industry trends and bringing drugs to market faster.

3Q Earnings: $186 million (earnings were $1.6B 3Q24) YTD Revenues: $44.5 billion (+8%) YTD Earnings: $2.4 billion (-44%) ...

Merck has entered a definitive agreement to acquire Cidara Therapeutics, a biotechnology company developing drug-Fc conjugate ...

TandemAI has secured a $22 million Series A extension to further develop its drug discovery platform, which combines advanced ...

Q Earnings: $5.8 billion (+83%) YTD Revenues: $48.6 billion (flat) YTD Earnings: $15.3 (+14%) Comments: KEYTRUDA sales were up 10% to $8.1 billion driven by continued global demand and uptake in ...

Global biopharmaceutical sales were $16.3 billion, down 6%. Primary Care sales were down 16% to $7.6 billion. Eliquis sales were up 22% to $2.0 billion. Prevnar sales were down 3% to $1.7 billion.

The U.S. Department of Health and Human Services (HHS) and the U.S. FDA, has appointed Richard Pazdur, M.D., as director of ...

Domain Therapeutics, a clinical-stage biopharmaceutical company, has appointed Jean-Marie Cuillerot, M.D., as Chief Medical ...

Neurvati Neurosciences, the neuroscience development platform of Blackstone Life Sciences, appointed Carlos Martin as Chief ...

BostonGene and Kyoto University have entered a research collaboration to develop advanced biological signatures.

Tech transfer in oral solid dose (OSD) manufacturing is one of the most critical, and often underestimated, phases in the ...

Panthera Biopartners, a UK Site Management Organization (SMO) which runs commercial clinical trials for the pharmaceutical ...